Company / SG&A Expense
PROCEPT BioRobotics Corp SG&A Expense History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$228.8M
FY2025
5-year range
$51.0M / $228.8M
FY2021-FY2025
Trend
+33.5%
vs FY2024
Sector context
#98 of 153
Health Care
What the data says
At $229M, PROCEPT BioRobotics Corp's sg&a expense ranks #56 of 153 in the Health Care sector. SG&A Expense has increased for 5 consecutive years, from $30M in FY2020 to $229M in FY2025.
Based on SEC 10-K filings.
$229M in FY2025 with a 5-year CAGR of +49.9%.
Increased from $132M to $229M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +37.1%
- 5-Year CAGR
- +49.9%
- 10-Year CAGR
- -
Sector benchmark
#56 of 153 in Health CareTop 36% of 153This company $228.8M Sector average $181.5B
▼
-99.9% below sector average
Key checks
Key Insights
- PROCEPT BioRobotics Corp's sg&a expense has grown for 5 consecutive years.
- 5-year CAGR of +49.9%, indicating consistent growth.
- In FY2025, sg&a expense increased 33.5% year-over-year.
- Ranks #98 out of 153 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $228.8M | +33.5% |
| FY2024 | $171.4M | +30.1% |
| FY2023 | $131.8M | +48.3% |
| FY2022 | $88.8M | +74.0% |
| FY2021 | $51.0M | +68.6% |
| FY2020 | $30.3M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026